David A. Siegel Orchard Therapeutics PLC Transaction History

Two Sigma Advisers, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.36 - $0.49 $576 - $784	1,600 Added 8.21%	21,100 $7,000
Q3 2022 Nov 14, 2022	BUY	$0.45 - $0.69 $8,775 - $13,454	19,500 New	19,500 $10,000
Q2 2022 Aug 15, 2022	SELL	$0.42 - $0.78 $6,678 - $12,402	-15,900 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.7 - $1.51 $121,659 - $262,438	-173,800 Reduced 91.62%	15,900 $11,000
Q4 2021 Feb 14, 2022	BUY	$1.16 - $2.23 $220,051 - $423,031	189,700 New	189,700 $250,000
Q1 2021 May 17, 2021	SELL	$4.39 - $9.08 $69,801 - $144,372	-15,900 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.86 - $5.07 $61,374 - $80,613	15,900 New	15,900 $69,000
Q3 2020 Nov 16, 2020	SELL	$4.11 - $6.45 $47,265 - $74,175	-11,500 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$5.75 - $11.99 $66,125 - $137,885	-11,500 Reduced 50.0%	11,500 $69,000
Q1 2020 May 15, 2020	BUY	$5.65 - $15.71 $129,950 - $361,330	23,000 New	23,000 $173,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.